The method will allow veterinarians to develop optimum treatment plans for canine cancer patients
|
The method will allow veterinarians to develop optimum treatment plans for canine cancer patients
|
Texas A&M’s veterinary college is developing a blood test to identify early cancer in dogs
|
Texas A&M’s veterinary college is developing a blood test to identify early cancer in dogs
|
ePARR is said to be more than 90 percent accurate across sample types
|
Eight hundred dogs will participate in the five-year trial
|
The new study was funded by the Morris Animal Foundation
|
Sir Desmond, a retired racing Greyhound, is the latest beneficiary
|
The school is teaming up with Canadian company NovaVive to conduct a clinical study
|
The Ontario-based company is teaming up with Iowa State University College of Veterinary Medicine to conduct a clinical study
|
Texas A&M associate professor to extend clinical trial for NuQ blood testing for canine cancer testing
|
Anpac Bio-Medical Science Co.’s liquid biopsy tech used to detect 20-plus human cancers with a single blood test could do the same for dogs
|
Dog deemed cancer-free after Echopulse
|
KPT-9274, combined with just one round of chemotherapy, is the focus of treating lymphoma in a clinical trial
|
The multi-year grant will support the largest-ever interventional canine clinical trial
|
Funds from the Blue Buffalo Foundation will help researchers develop more effective drug therapies
|
Oakland Veterinary Referral Services is looking nationwide for dogs suffering from stage II splenic hemangiosarcoma to submit for study, herbal treatment
|
|
|
